Latest & greatest articles for pneumonia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pneumonia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pneumonia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pneumonia

101. CRACKCast E076 – Pneumonia

CRACKCast E076 – Pneumonia CRACKCast E076 - Pneumonia - CanadiEM CRACKCast E076 – Pneumonia In , by Adam Thomas May 8, 2017 This episode of CRACKCast covers Rosen’s Chapter 76, Pneumonia. This episode tackles high yield information on diagnosis and management of pneumonia, one of the most common emergency department presenting illnesses. Shownotes – Rosen’s in Perspective This is a common disease – thankfully most cases can be managed as an outpatient, however, this is expected to change (...) 10,000 L of air each day!! Pneumonia develops when: Host defences are overwhelmed A Virulent organism shows up A large amount of oropharyngeal organisms is aspirated Typical vs Atypical infections Typical ones: Streptococcus pneumoniae (very virulent) Haemophilus influenzae Staphylococcus aureus CA MRSA can commonly be associated with influenzae IVDU’s Look for the cavitation, and necrosis on the CXR Atypicals Legionella Mycoplasma Chlamydophila Virals: Influenzae Parainfluenza Usually named

2017 CandiEM

102. Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias Full Text available with Trip Pro

Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias Although acute exacerbation of idiopathic interstitial pneumonias (IIPs) is a lethal complication after pulmonary resection for lung cancer with IIPs, there are no established methods to prevent its occurrence. This prospective randomized study was conducted to evaluate whether perioperative administration of the neutrophil elastase inhibitor sivelestat prevents acute exacerbation after

2017 EvidenceUpdates

103. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease Full Text available with Trip Pro

Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease Knowledge regarding whether benzodiazepines and similarly acting non-benzodiazepines (Z-drugs) are associated with an increased risk of pneumonia among older adults is lacking. We sought to investigate this association among community-dwelling adults with Alzheimer disease, a condition in which both sedative/hypnotic use and pneumonia are common.We obtained data on all community (...) -dwelling adults with a recent diagnosis of Alzheimer disease in Finland (2005-2011) from the Medication use and Alzheimer disease (MEDALZ) cohort, which incorporates national registry data on prescriptions, reimbursement, hospital discharges and causes of death. Incident users of benzodiazepines and Z-drugs were identified using a 1-year washout period and matched with nonusers using propensity scores. The association with hospital admission or death due to pneumonia was analyzed with the Cox

2017 EvidenceUpdates

104. Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD Full Text available with Trip Pro

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD Serum procalcitonin (PCT) and C-reactive protein (CRP) are markers of systemic inflammation and bacterial infection. We aimed to compare the usefulness of procalcitonin and CRP in patients with community-acquired pneumonia and exacerbations of chronic obstructive pulmonary disease (COPD).A total of 116 consecutive patients were included in the study: 76 with chronic obstructive (...) pulmonary disease in group 1, and 40 with pneumonia in group 2.Median serum CRP level was 44 mg/L in the COPD group and 132 mg/L in the pneumonia group. Median value of serum PCT was found to be 0.07 in the COPD group and 0.14 ng/mL in the pneumonia group. Serum PCT and CRP levels were significantly higher in the pneumonia group compared to the COPD group (p<0.001). The area under the ROC curve was 0.788 (CI: 0.704-0.872) for CRP and 0.699 (CI: 0.599-0.800) for procalcitonin to identify

2017 Journal of medical biochemistry

105. The mask of acute bacterial pneumonia may disguise the face of tuberculosis Full Text available with Trip Pro

The mask of acute bacterial pneumonia may disguise the face of tuberculosis Pulmonary tuberculosis (TB) can present as acute pneumonia. Differentiation of tuberculous from non-tuberculous community-acquired pneumonia (CAP) is an important challenge in endemic areas. The purpose of this study was the comparison between characteristics of tuberculous and non-tuberculous CAP patients.In this prospective and observational study, all adult patients (aged ≥16 years) who were admitted to Imam Reza (...) Hospital in Mashhad (Iran) with the diagnosis of CAP, between February 2013 and January 2014, were enrolled. Clinical, radiological, and microbiological data of the patients were collected and reviewed. Statistical analyses were performed using SPSS 14 software and R programming language.We studied 120 patients with diagnosis of acute CAP including 21 (17.5%) tuberculous and 99 (82.5%) non-tuberculous CAP. The etiologies of CAP in the latter group were as follow: S. pneumoniae 29 (29.3%), followed by S

2017 Electronic physician

106. Increased incidence of adult pneumococcal pneumonia during school holiday periods Full Text available with Trip Pro

Increased incidence of adult pneumococcal pneumonia during school holiday periods Child contact is a recognised risk factor for adult pneumococcal disease. Peaks in invasive pneumococcal disease incidence observed during winter holidays may be related to changes in social dynamics. This analysis was conducted to examine adult pneumococcal community-acquired pneumonia (CAP) incidence during school holiday periods. Between September 2008 and 2013, consecutive adults admitted to hospitals covering (...) the Greater Nottingham area with a diagnosis of CAP were studied. Pneumococcal pneumonia was detected using culture and antigen detection methods. Of 2221 adults studied, 575 (25.9%) were admitted during school holidays and 643 (29.0%) had pneumococcal CAP. CAP of pneumococcal aetiology was significantly more likely in adults admitted during school holidays compared to term time (35.3% versus 26.7%; adjusted OR 1.38, 95% CI 1.11-1.72, p=0.004). Over the 5-year period, the age-adjusted incidence

2017 ERJ open research

107. Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. Full Text available with Trip Pro

Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. Objective To determine the attributable risk of community acquired pneumonia on incidence of heart failure throughout the age range of affected patients and severity of the infection.Design Cohort study.Setting Six hospitals and seven emergency departments in Edmonton, Alberta, Canada, 2000-02.Participants 4988 adults with community acquired pneumonia and no history of heart (...) failure were prospectively recruited and matched on age, sex, and setting of treatment (inpatient or outpatient) with up to five adults without pneumonia (controls) or prevalent heart failure (n=23 060).Main outcome measures Risk of hospital admission for incident heart failure or a combined endpoint of heart failure or death up to 2012, evaluated using multivariable Cox proportional hazards analyses.Results The average age of participants was 55 years, 2649 (53.1%) were men, and 63.4% were managed

2017 BMJ

108. Bedside lung ultrasound for the diagnosis of pneumonia in children

Bedside lung ultrasound for the diagnosis of pneumonia in children BestBets: Bedside lung ultrasound for the diagnosis of pneumonia in children Bedside lung ultrasound for the diagnosis of pneumonia in children Report By: Louis-David Audette - PGY-4, emergency medicine Search checked by Marc-Charles Parent - MD, FRCPC Institution: Emergency Medicine Residency Program, Laval University Date Submitted: 20th January 2016 Date Completed: 10th February 2017 Last Modified: 10th February 2017 Status (...) : Green (complete) Three Part Question In [children] presenting with suspected pneumonia), can [bedside lung ultrasound] be used to diagnose [pneumonia]? Clinical Scenario A 4 year-old child presents to your local ED with respiratory symptoms and fever. In order to confirm your suspicion of pneumonia, you plan to order a chest radiograph, but a quick look into the child's medical record shows he has already undergone several X-rays in the last few years for the evaluation of upper respiratory tract

2017 BestBETS

109. Household expenditures on pneumonia and diarrhoea treatment in Ethiopia: a facility-based study Full Text available with Trip Pro

Household expenditures on pneumonia and diarrhoea treatment in Ethiopia: a facility-based study Out-of-pocket (OOP) medical payments can lead to catastrophic health expenditure and impoverishment. We quantified household OOP expenditure for treatment of childhood pneumonia and diarrhoea and its impact on poverty for different socioeconomic groups in Ethiopia.This study employs a mix of retrospective and prospective primary household data collection for direct medical and non-medical costs (2013 (...) US$). Data from 345 pneumonia and 341 diarrhoea cases (0-59 months of age) were collected retrospectively through exit interviews from 35 purposively sampled health facilities in Ethiopia. Prospective 2-week follow-up interviews were conducted at the household level using a structured questionnaire.The mean total medical expenditures per outpatient visit were US$8 for pneumonia and US$6 for diarrhoea, while the mean for inpatient visits was US$64 for severe pneumonia and US$79 for severe

2017 BMJ global health

110. In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids

In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids | BMJ Evidence-Based Medicine We use cookies to improve our service (...) name or password? You are here In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids Article Text Commentary General medicine In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids

2017 Evidence-Based Medicine

120. Antibiotics for pediatric outpatients with community-acquired pneumonia

Antibiotics for pediatric outpatients with community-acquired pneumonia

2017 DynaMed Plus